Acetaminophen News and Research

RSS
The pain-reliever acetaminophen (also known as paracetomol) is one of the best-selling over-the-counter medications, used by more than 200 million Americans a year. It is sold under many brand names, including Tylenol, and is an ingredient in nearly 200 medications, both over-the-counter (such as Excedrin, Midol, NyQuil, and Sudafed) and prescription (such as Vicodin).
Labopharm announces European approval of twice-daily tramadol-acetaminophen

Labopharm announces European approval of twice-daily tramadol-acetaminophen

Research-based tip sheets provide details on breast cancer

Research-based tip sheets provide details on breast cancer

IV ibuprofen effective in reducing fever in hospitalized patients

IV ibuprofen effective in reducing fever in hospitalized patients

Nautilus Neurosciences announces exclusive co-promotion agreement for CAMBIA drug

Nautilus Neurosciences announces exclusive co-promotion agreement for CAMBIA drug

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Merck to appeal against jury verdict in retrial of federal FOSAMAX case

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Headaches, back pain and arthritis cost companies more than $61 billion per annum

Headaches, back pain and arthritis cost companies more than $61 billion per annum

APF launches new educational initiative for people with pain, health care professionals

APF launches new educational initiative for people with pain, health care professionals

Genzyme announces Japanese approval of Synvisc viscosupplement for OA knee pain relief

Genzyme announces Japanese approval of Synvisc viscosupplement for OA knee pain relief

Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010

Purdue Pharma to present Butrans Transdermal System CIII clinical program data at PAINWeek 2010

Study: IV ibuprofen decreases pain, morphine use in pre and post-operative orthopedic surgery patients

Study: IV ibuprofen decreases pain, morphine use in pre and post-operative orthopedic surgery patients

FDA extends review on Acetadote for non-acetaminophen acute liver failure

FDA extends review on Acetadote for non-acetaminophen acute liver failure

Cumberland Pharmaceuticals reports 9% increase in second quarter 2010 net revenue

Cumberland Pharmaceuticals reports 9% increase in second quarter 2010 net revenue

Study identifies use of acetaminophen may increase asthma symptoms in adults

Study identifies use of acetaminophen may increase asthma symptoms in adults

Labopharm second-quarter total revenue increases to $6.8 million

Labopharm second-quarter total revenue increases to $6.8 million

Labopharm launches antidepressant OLEPTRO for major depressive disorder in U.S.

Labopharm launches antidepressant OLEPTRO for major depressive disorder in U.S.

NeurogesX net loss for second-quarter 2010 increases to $10.2 million

NeurogesX net loss for second-quarter 2010 increases to $10.2 million

Cornerstone Therapeutics second-quarter total net revenues increase 14% to $28.5 million

Cornerstone Therapeutics second-quarter total net revenues increase 14% to $28.5 million

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Mental-health treatment could reduce pain in osteoarthritis patients: Study

Mental-health treatment could reduce pain in osteoarthritis patients: Study